ODAIA completes Series C funding round

The funding round was supported by strategic investor PHM, a US health media agency and part of Publicis Groupe, with returning investors from earlier funding rounds including BDC Capital, Flint Capital, Innospark Ventures, Graphite Ventures, Threshold Ventures and Wittington Ventures.
ODAIA helps predict patient journeys and to understand which healthcare professionals to prioritise through which channels. The company is based in Toronto and Boston.
The funding will be used to expand the business, including developing its commercial intelligence platform.
Philip Poulidis, chief executive and co-founder at ODAIA, said: “This round lets us go deeper with the enterprise customers we already serve and, with PHM, bring that infrastructure to more of the industry.”
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.







0 Comments